FLT3 and acute myeloid leukemia: Finally, the World Health Organization (WHO)’s classification of myeloid neoplasms and acute leukemia [8] does not specifically stratify AML by risk based on specific mutation but includes FLT3-ITD as an alteration with clinical significance.